Boogie Board Jot 8.5 LCD eWriter- Gray
Last verified June 17, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
The Boogie Board Jot 8.5 is a reusable LCD writing tablet — you write on it with the included stylus and the high-contrast display holds your message until you press the erase button. It's a practical low-tech communication tool for someone who can't speak temporarily or permanently, such as after a stroke, with vocal cord damage, ALS, or significant hearing loss — anyone who needs a quick, portable way to write notes for others to read. The device works completely on its own with no apps, charging, or connectivity required, though there is a companion mobile app available for additional features. The main limitation is that it only displays one message at a time with no memory or save function, so once you erase, the content is gone.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- Vocational rehab
What Setup Looks Like
- Out of the box
- Remove from packaging — the writing surface is active immediately, no power-on required.
- Write with the included stylus; press the erase button to clear and start over.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from Kent Displays — view on vendor site; last verified June 17, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.